Discover
IVI’s laboratories in Seoul contain microbiological, immunological, and genomic capabilities. They include BSL-3 and BSL-2 labs, other labs that adhere to Good Clinical Laboratory Practice standards, and animal facilities.
Our lab science division designs new vaccines and improves the formulation of existing vaccines. It conducts preclinical studies, evaluates the safety and performance of promising vaccine candidates, and develops technologies to support vaccine clinical testing. The lab science teams also optimize production processes to support industrial-level scale-up and transfer vaccine technologies to manufacturers.
All IVI technology transfers require that selected manufacturers produce high-quality vaccines at low cost in a country with a functional National Regulatory Authority accredited by the World Health Organization.
IVI’s vaccines
Low-cost
Easy to administer in resource-limited settings
Easily produced by manufacturers in low- and middle-income countries
